Fundraising FoxEmerald Health Pharmaceuticals
San Diego, US · Founded 2017 · Delaware corporation
Find your way into Emerald Health Pharmaceuticals
Sign up to see every warm intro you have to Emerald Health Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Emerald Health Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JS
Joachim SchuppChief Medical Officer
EM
Eduardo MunozChief Scientific Officer
JD
James DeMesaPresident, Chief Executive Officer and Director
AR
Alain RollandChief Operating Officer
LS
Lisa SanfordChief Financial Officer
Board
JL
James L. HeppellBoard director
GA
Gaetano A. MorelloBoard director
PD
Punit DhillonBoard director
Reported raises · per SEC filings
Form D private placements$3.3M disclosed across 4 of 5 rounds · 2017–2021
▶$300KraisedJul 2021 · 1 investors · PharmaceuticalsRule 506(b)
▶$300KraisedJul 2021 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Punit DhillonDirector
- James DeMesaExecutive Officer, Director
- Lisa SanfordExecutive Officer
- Eduardo MunozExecutive Officer
- Alain RollandExecutive Officer
- James HeppellDirector
- Joachim SchuppExecutive Officer
- Nancy CoulsonExecutive Officer
- Gaetano MorelloDirector
- Amount sold
- $300K
- Minimum investment
- $100K
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$500KraisedApr 2021 · 1 investors · PharmaceuticalsRule 506(b)
▶$500KraisedApr 2021 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Joachim SchuppExecutive Officer
- Eduardo S. MunozExecutive Officer
- James L. HeppellDirector
- James DeMesaExecutive Officer, Director
- Alain RollandExecutive Officer
- Lisa SanfordExecutive Officer
- Gaetano A. MorelloDirector
- Punit DhillonDirector
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Apr 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$2.5MraisedJun 2019 · 1 investors · PharmaceuticalsRule 506(b)
▶$2.5MraisedJun 2019 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Avtar S. DhillonExecutive Officer, Director
- James DeMesaExecutive Officer
- Lisa SanfordExecutive Officer
- Alain RollandExecutive Officer
- Punit S. DhillonDirector
- Eduardo MunozExecutive Officer
- James L. HepellDirector
- Gaetano A. MorelloDirector
- Joachim SchuppExecutive Officer
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$1KraisedMar 2017 · 5 investors · PharmaceuticalsRule 506(b)
▶$1KraisedMar 2017 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jill BroadfootExecutive Officer
- Punit DhillonDirector
- Avtar DhillonExecutive Officer, Director
- Gaetano MorelloDirector
- Jim HeppellDirector
- Jim DeMesaExecutive Officer
- Offering amount
- $1K
- Amount sold
- $1K
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Emerald Health Pharmaceuticals raised?
- Emerald Health Pharmaceuticals has disclosed $3.3M raised across 4 of its 5 known rounds.
- Where is Emerald Health Pharmaceuticals headquartered?
- Emerald Health Pharmaceuticals is headquartered in San Diego, US.